Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial

Peter D. Cole, Kathleen M. McCarten, Qinglin Pei, Menachem Spira, Monika L. Metzger, Richard A. Drachtman, Terzah M. Horton, Rizvan Bush, Susan M. Blaney, Brenda J. Weigel, Kara M. Kelly

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences